骨髓系衍生抑制细胞:与骨髓系恶性瘤和免疫治疗有关
Suncica Kapor1, Milica Radojković2, Juan F Santibanez3
1Department of Hematology, Clinical, and Hospital Center "Dr. Dragiša Mišović-Dedinje,", Heroja Milana Tepića 1, Belgrade 11020, Serbia.
Acta histochemica
|July 19, 2024
概括
骨髓质恶性瘤涉及异常干细胞. 骨髓原抑制细胞 (MDSC) 抑制免疫力,促进癌症生长,向它们可能改善癌症疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 骨髓性恶性瘤起源于造血干细胞,包括急性骨髓性白血病等疾病.
- 骨髓原抑制细胞 (MDSCs) 在免疫调节中起着至关重要的作用.
- 通过抑制免疫反应,MDSCs创造了有利于瘤生长的环境.
研究的目的:
- 审查骨髓性恶性瘤中MDSCs的特征.
- 要突出增加的MDSC数量和增强的免疫抑制之间的相关性.
- 分析针对MDSC的联合癌症疗法的潜力.
主要方法:
- 文献综述,重点关注骨髓性恶性瘤中MDSC特征.
- 分析MDSC在瘤微环境中的免疫耐受性中的作用.
- 探索针对MDSC生成,扩展和功能的治疗策略.
主要成果:
- 增加的MDSC计数与增加的免疫抑制能力有关.
- MDSCs培养了一个免疫耐受性的微环境,支持瘤的进展.
- 针对MDSCs是一个有前途的策略,可以增强当前的癌症免疫疗法.
结论:
- 了解MDSC的含义对于推进骨髓性恶性瘤治疗至关重要.
- 针对MDSC的组合疗法可能会提高癌症免疫疗法的疗效.
- 对MDSC专注策略的进一步研究可能会导致神经质恶性瘤的新型治疗应用.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cytotoxic T Cells-mediated Immune Response
885
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
885


